Prospects for Gene Therapy Using HIV-Based Vectors

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Somatic Cell Genetics

• Publication date

  2001-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1021034931852PMID 12465467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Virus Entry into Animal Cells

  2008cited by this paper
• Locus Control Region of the Human CD2Gene in a Lentivirus Vector Confers Position-Independent Transgene Expression

  2001cited by this paper
• Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.

  2001cited by this paper
• Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.

  2000cited by this paper
• Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector

  2000cited by this paper
• The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells.

  2000cited by this paper
• Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins.

  2000cited by this paper
• A stable system for the high-titer production of multiply attenuated lentiviral vectors.

  2000cited by this paper
• Lentiviral vectors for enhanced gene expression in human hematopoietic cells.

  2000cited by this paper
• Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.

  2000cited by this paper
• Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells.

  2000cited by this paper
• Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.

  2000cited by this paper
• A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1gag-pol Gene

  2000cited by this paper
• Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin

  2000cited by this paper
• Complete and Long-Term Rescue of Lesioned Adult Motoneurons by Lentiviral-Mediated Expression of Glial Cell Line-Derived Neurotrophic Factor in the Facial Nucleus

  2000cited by this paper
• Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

  2000cited by this paper
• High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors.

  2000cited by this paper
• A Packaging Cell Line for Lentivirus Vectors

  1999cited by this paper
• Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells.

  1999cited by this paper
• Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure.

  1999cited by this paper
• Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

  1999cited by this paper
• Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

  1999cited by this paper
• Rescue from Photoreceptor Degeneration in therd Mouse by Human Immunodeficiency Virus Vector-Mediated Gene Transfer

  1999cited by this paper
• HIV-1 replication in patients with undetectable plasma virus receiving HAART

  1999cited by this paper
• Requirements for Efficient Production and Transduction of Human Immunodeficiency Virus Type 1-Based Vectors

  1999cited by this paper
• Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.

  1999cited by this paper
• Contributions of Viral Splice Sites andcis-Regulatory Elements to Lentivirus Vector Function

  1999cited by this paper
• Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV‐infected subjects with highly active anti‐retroviral therapy (HAART) or HAART + IL‐2

  1999cited by this paper
• Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy.

  1999cited by this paper
• Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.

  1999cited by this paper
• Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

  1999cited by this paper
• Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

  1999cited by this paper
• High prevalence of multiple drug resistance mutations in a UK HIV/AIDS patient population.

  1999cited by this paper
• Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.

  1999cited by this paper
• Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations.

  1999cited by this paper
• Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

  1999cited by this paper
• Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

  1999cited by this paper
• Stable Integration of Human Immunodeficiency Virus-Based Retroviral Vectors into the Chromosomes of Nondividing Cells

  1998cited by this paper
• Targeting Human Immunodeficiency Virus Type 1 Reverse Transcriptase by Intracellular Expression of Single-Chain Variable Fragments To Inhibit Early Stages of the Viral Life Cycle

  1998cited by this paper
• Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals.

  1998cited by this paper
• Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor.

  1998cited by this paper
• A Third-Generation Lentivirus Vector with a Conditional Packaging System

  1998cited by this paper
• Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

  1998cited by this paper
• Vpr Stimulates Viral Expression and Induces Cell Killing in Human Immunodeficiency Virus Type 1-Infected Dividing Jurkat T Cells

  1998cited by this paper
• Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

  1998cited by this paper
• Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1

  1998cited by this paper
• Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor.

  1998cited by this paper
• Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus

  1998cited by this paper
• Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing.

  1998cited by this paper
• Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys

  1998cited by this paper
• HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells.

  1998cited by this paper
• Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral‐experienced patients in advanced stages of HIV‐1 infection

  1998cited by this paper
• Expression pattern of CD2 locus control region containing retroviral vectors in hemopoietic cells in vitro and in vivo

  1998cited by this paper
• Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.

  1998cited by this paper
• Virological failure and adherence to antiretroviral therapy in HIV-infected patients.

  1998cited by this paper
• Development of a Self-Inactivating Lentivirus Vector

  1998cited by this paper
• Human Immunodeficiency Virus Type 1 Vectors Efficiently Transduce Human Hematopoietic Stem Cells

  1998cited by this paper
• Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Toward HIV eradication or remission: the tasks ahead.

  1998cited by this paper
• Anti-HIV Type 1 Activity of Wild-Type and Functional Defective RANTES Intrakine in Primary Human Lymphocytes

  1998cited by this paper
• Retroviral Stem Cell Gene Therapy

  1997cited by this paper
• Protection of Primary Human T Cells from HIV Infection by Trev: A Transdominant Fusion Gene

  1997cited by this paper
• Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection.

  1997cited by this paper
• Intracellular antibodies (intrabodies) for gene therapy of infectious diseases.

  1997cited by this paper
• In Vitro and In Vivo Tumor Growth Suppression by HIV-1 Vpr

  1997cited by this paper
• Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector

  1997cited by this paper
• HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.

  1997cited by this paper
• Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector.

  1997cited by this paper
• Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.

  1997cited by this paper
• A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells.

  1997cited by this paper
• Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication

  1997cited by this paper
• Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

  1997cited by this paper
• Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy

  1997cited by this paper
• Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection.

  1997cited by this paper
• Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

  1997cited by this paper
• Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection

  1997cited by this paper
• Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

  1997cited by this paper
• Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

  1997cited by this paper
• Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.

  1997cited by this paper
• Inhibition of Early and Late Events of the HIV-1 Replication Cycle by Cytoplasmic Fab Intrabodies against the Matrix Protein, p17

  1997cited by this paper
• Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

  1997cited by this paper
• Codon usage limitation in the expression of HIV-1 envelope glycoprotein.

  1996cited by this paper
• Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.

  1996cited by this paper
• Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system.

  1996cited by this paper
• Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

  1996cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Gene Therapy for AIDS Using Retroviral Mediated Gene Transfer to Deliver HIV-1 Antisense TAR and Transdominant Rev Protein Genes to Syngeneic Lymphocytes in HIV-1 Infected Identical Twins. National Institutes of Health, Bethesda, Maryland

  1996cited by this paper
• Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.

  1996cited by this paper
• Vaccine protection by a triple deletion mutant of simian immunodeficiency virus

  1996cited by this paper
• A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

  1996cited by this paper
• Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.

  1996cited by this paper
• Both virus and host components are important for the manifestation of a Nef- phenotype in HIV-1 and HIV-2.

  1995cited by this paper
• Mutations in the PDE6B gene in autosomal recessive retinitis pigmentosa.

  1995cited by this paper
• Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients

  1995cited by this paper
• HIV accessory proteins: leading roles for the supporting cast.

  1995cited by this paper
• Differential regulation of motor neuron survival and choline acetyltransferase expression following axotomy.

  1995cited by this paper
• An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy

  1995cited by this paper
• Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa.

  1995cited by this paper
• HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization.

  1994cited by this paper

• Feasibility of lentiviral‑mediated sodium iodide symporter gene delivery for the efficient monitoring of bone marrow‑derived mesenchymal stem cell transplantation and survival.

  2014cites this paper
• Transplantation d'hépatocytes génétiquement modifiés : régénération hépatique et moyens d'amélioration de la prise de greffe hépatocytaire

  2012cites this paper
• Therapeutic effect of transplanting β2m−/Thy1+ bone marrow‐derived hepatocyte stem cells transduced with lentiviral‐mediated HGF gene into CCl4‐injured rats

  2010cites this paper
• Efficient hepatocyte engraftment and long‐term transgene expression after reversible portal embolization in nonhuman primates

  2009cites this paper
• Treatment of lysosomal storage disorders: focus on the neuronal ceroid-lipofuscinoses.

  2008cites this paper
• The status of gene vectors for the treatment of diabetes

  2007cites this paper
• Function and Mechanism of Chromatin Boundaries

  2006cites this paper
• Gene therapy for cardiovascular applications

  2005cites this paper
• An epoch-making application of discharge plasma phenomenon to gene-transfer.

  2005cites this paper
• Gene Therapy Using Encapsulated Cells

  2005cites this paper
• Adeno‐associated viral vectors for gene therapy

  2005cites this paper
• Gene therapy in clinical medicine

  2004cites this paper
• Gene therapy in clinical medicine

  2004cites this paper